Acetazolamide-Responsive Episodic Ataxia Syndrome
Neurol 33:1212-1214, Zasorin,N.L.,et al, 1983

Memory Enhancement with Oral Physostigmine in Alzheimer's Disease
NEJM 308:720-721, Thal,L.J.,et al, 1983

Oral Physostigmine & Lecithin Improve Memory in Alzheimer Disease
Ann Neurol 13:491-496, Thal,L.J.,et al, 1983

Vitamin E & Neurological Function
Lancet 1:225-228, Muller,D.P.R.,et al, 1983

Aldose Reductase Inhibition Improves Nerve Conduction Velocity In Diabetic Patients
NEJM 308:119-125, Judzewitsch,R.G.,et al, 1983

Protective Effect of Vitamin E (DL-Alpha-Tocopherol) Against Intraventricular Haemorrhage in Premature Babies
BMJ 287:81-84, Chiswick,M.L.,et al, 1983

Chronic Inflammatory Polyradiculoneuropathy Complicated by Factor VIII Antibody
Neurol 33:1224-1226, Berger,J.R.,et al, 1983

Memory Decline in the Aged:Treatment with Lecithin & Physostigmine
Neurol 32:944-950, Drachman,D.A.,et al, 1982

Central Sleep Apnea, Improvement With Acetazolamide Therapy
Arch Int Med 142:1816-1819, White,D.P.,et al, 1982

Spinocerebellar Degeneration Secondary to Chronic Intestinal Malabsorption:A Vitamin E Deficiency Syndrome
Ann Neurol 12:419-424, Harding,A.E.,et al, 1982

Deprenyl In Parkinson's Disease
Lancet 2:695-696, , 1982

Double-blind, Triple-crossover Trial of Low Doses of Oral Physostigmine in Inherited Ataxias
Neurol 31:288-292, Kark,R.A.P.,et al, 1981

Plasma Pyridostigmine Levels in Myasthenia Gravis
Neurol 31:145-150, White,M.C.,et al, 1981

Acute Effects of Acetazolamide in Hyperkalemic Periodic Paralysis
Neurol 31:725-729, Riggs,J.E.,et al, 1981

Deprenyl in Parkinson Disease
Neurol 31:19-23, Eisler,T.,et al, 1981

Association Of Spinocerebellar Disorders With Cystic Fibrosis Or Chronic Childhood Cholestasis & Very Low Serum Vit. E
Lancet 2:1319-1321, Elias,E.,et al, 1981

Vitamin E Deficiency in Werdnig-Hoffmann Disease
Ann Neurol 10:266-268, Shapira,Y.,et al, 1981

Amitriptyline-induced Ophthalmoplegia
Neurol 31:1188-1190, Spector,R.H.,et al, 1981

Physostigmine In Gilles De La Tourettes Syndrome
NEJM 302:298, Stahl,S.M.,et al, 1980

Increased Dosage of Carbidopa in Patients with Parkinson's Disease Receiving Low Doses of Levodopa
Arch Neurol 37:146-149, Hoehn,M.M., 1980

Memory & Cognitive Function in the Elderly, A Preliminary Trial of Physostigmine
Arch Neurol 37:674-675, Drachman,D.A.,et al, 1980

Abetalipoproteinemia, Report of Two Cases & Review of Therapy
Arch Neurol 37:659-662, Illingworth,D.R.,et al, 1980

Acetazolamide-Induced Improvement in Hydro-cephalus
Arch Neurol 37:376, Donat,J.F., 1980

Proximal Myopathy after Prolonged Total Therapeutic Starvation
BMJ 280:1212-1213, Scobie,I.N.,et al, 1980

Controversies About the Treatment of Myasthenia Gravis
JNNP 43:644-659, Rowland,L.P., 1980

Increased Ratio of Carbidopa to Levodopa in Treatment of Parkinson's Disease
Arch Neurol 37:723-726, Tourtellotte,W.W.,et al, 1980

Sinemet-25/100
Medical Letter, 22:511980., , 1980

Acquired Hemophilia, Meningioma, & Diphenyl-hydantoin Therapy
J Neurosurg 53:600-605, O'Reilly,R.A.,et al, 1980

Anticholinergic Toxicity
NEJM 300:1278, Caine,E.D., 1979

Physostigmine in Reye Syndrome
Ann Neurol 5:105, Pettegrew,J.W.,et al, 1979

Effects of Physostigmine & Lecithin on Memory in Alzheimer Disease
Ann Neurol 6:219-221, Peters,B.H.,et al, 1979

Enhancement Of Memory By Physostigmine
NEJM 301:946, Davis,K.L.,et al, 1979

Meige Disease:Striatal Dopaminergic Preponderance
Neurol 29:1126-1130, Tolosa,E.S.,et al, 1979

Familial Periodic Ataxia
Arch Neurol 36:568-569, Donat,J.R.,et al, 1979

Reversibility of Human Myopathy Caused by Vitamin E Deficiency
Neurol 29:1182-1186, Tomasi,L.G., 1979

Effects of Acetazolamide on Myotonia
Ann Neurol 3:531, Griggs,R.C.,et al, 1978

Considerations in the Management of Parkinsonism
Neurol 28:5, Fahn,S.,et al, 1978

Amantadine Intoxication Reversed by Physostigmine
NEJM 298:516, Casey,D.E., 1978

Comparative Effectiveness of Two Extracerebral DOPA Decarboxylase Inhibitors in Parkinson Disease
Neurol 28:964-968, Lieberman,A.,et al, 1978

Hereditary Paroxysmal Ataxia:Response to Acetazolamide
Neurol 28:1259-1264, Griggs,R.C.,et al, 1978

Physostigmine in Familial Ataxias
Neurol 27:70, Kark,R.A.,et al, 1977

Drug Therapy of Tardive Dyskinesia
NEJM 296:257, Kobayashi,R.M., 1977

Purine Phosphoribosyltransferase in Gilles de la Tourette Syndrome
NEJM 296:210, VanWoert,M.H.,et al, 1977

Pheniramine Aminosalicylate Overdosage:Reversal of Delirium & Choreiform Movements with Tacrine Treatment
Arch Neurol 34:313, Mendelson,G.,et al, 1977

Degeneration of Fasciculus Gracilis in Cystic Fibrosis
Neurol 27:185, Geller,A.,et al, 1977

Newer Concepts in Management of Migraine Headaches
J Med Soc N J 74:11, Haidri,N.H.,et al, 1977

Clofibrate-Induced Muscle Damage with Myoglobinuria & Cardiomyopathy
NEJM 296:942, Smals,A.G.H., 1977

Malabsorption of Pyridostigmine in Patients with Masthenia Gravis
Neurol 27:299, Cohan,S.L.,et al, 1977

Total Gaze Paresis in Amitriptyline Overdose
Neurol 27:695, Miadinich,E.K.,et al, 1977

Long-term Therapy of Myoclonus & Other Neurologic Disorders with L-5-Hydroxytryptophan & Carbidopa
NEJM 296:70, VanWoert,M.H.,et al, 1977